STRATA Skin Sciences, Inc. (SSKN)

0.4147 -0.0024 (-0.58%) As of 09:41AM EDT. Market open.

STRATA Skin Sciences, Inc.

5 Walnut Grove Drive
Suite 140
Horsham, PA 19044
United States
215 619 3200
https://www.strataskinsciences.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 99

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Dolev Rafaeli Ph.D.	President, CEO & Vice-Chairman	408.71k	N/A	1964
Mr. Christopher Lesovitz	Chief Financial Officer	493.19k	N/A	1983
Mr. Shmuel Gov	Chief Operating Officer	490.44k	N/A	1960
Mr. Jay Sturm	General Counsel & Corporate Secretary	N/A	N/A	1956
Mr. Michael R. Stewart	Independent Consultant	732.9k	N/A	1957

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.

Corporate governance

STRATA Skin Sciences, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.